The Role of Human Equilibrative Nucleoside Transporter 1 on the Cellular Transport of the DNA Methyltransferase Inhibitors 5-Azacytidine and CP-4200 in Human Leukemia Cells-Reference-Cited by-同舟云学术

The Role of Human Equilibrative Nucleoside Transporter 1 on the Cellular Transport of the DNA Methyltransferase Inhibitors 5-Azacytidine and CP-4200 in Human Leukemia Cells

Published:2013-06-28 Issue:3 Volume:84 Page:438-450
ISSN:0026-895X
Container-title:Molecular Pharmacology
language:en
Short-container-title:Mol Pharmacol

Author:

Hummel-Eisenbeiss Johanna,Hascher Antje,Hals Petter-Arnt,Sandvold Marit Liland,Müller-Tidow Carsten,Lyko Frank,Rius Maria

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference38 articles.

1. Breast Cancer Resistance Protein and P-Glycoprotein in 149 Adult Acute Myeloid Leukemias

2. MRP3, BCRP, and P-Glycoprotein Activities are Prognostic Factors in Adult Acute Myeloid Leukemia

3. Human equilibrative nucleoside transporter 1 (hENT1) expression is a potential predictive tool for response to gemcitabine in patients with advanced cholangiocarcinoma

4. Delivery of 5-Azacytidine to Human Cancer Cells by Elaidic Acid Esterification Increases Therapeutic Drug Efficacy

5. High-throughput SNP-based authentication of human cell lines

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Decitabine cytotoxicity is promoted by dCMP deaminase DCTD and mitigated by SUMO-dependent E3 ligase TOPORS;The EMBO Journal;2024-05-17

2. Research progress and applications of epigenetic biomarkers in cancer;Frontiers in Pharmacology;2024-04-12

3. The dCMP deaminase DCTD and the E3 ligase TOPORS are central mediators of decitabine cytotoxicity;2023-12-21

4. Mechanisms of resistance to hypomethylating agents and BCL-2 inhibitors;Best Practice & Research Clinical Haematology;2023-12

5. Targeting tumor endothelial cells with methyltransferase inhibitors: Mechanisms of action and the potential of combination therapy;Pharmacology & Therapeutics;2023-07